Huntsville, AL
2537 Sparkman Dr NW, Huntsville, AL, 35810-3825In T1D, hyperglycemia and poor glycemic control impact cardiovascular outcomes, including blood pressure and cholesterol levels. Therapies such as ACE inhibitors, ARBs, statins, and other lipid-lowering drugs may be prescribed to manage cardiovascular disease and reduce the risk of cardiovascular complications.
Pramlintide is a synthetic amylin analog administered via syringe. It is approved for people with T1D who use mealtime insulin and do not achieve their glycemic targets despite optimal insulin therapy. Pramlintide limits glucose fluctuations after meals. Pramlintide therapy can also lead to weight loss and improvements in risk factors for cardiovascular disease.
Adjunctive therapies complement insulin to achieve better glucose control.
Managing type 1 diabetes involves three main steps: checking blood sugar, administering insulin, and counting carbohydrates.
Disease-modifying therapies prevent, slow, halt, or reverse T1D progression.
Insulin is the primary type 1 diabetes treatment. People with type 1 diabetes must take insulin to survive because their body does not make enough of it. Insulin is administered by injection, inhalation, or insulin pump. There are several different types of insulin used today, with most individuals with T1D using basal (long-acting) and bolus (short-acting) insulins.
Learn more about symptoms, causes, biology, diagnosis, and frequently asked questions about type 1 diabetes.
A look at the most common type 1 diabetes complications and ways they can be prevented or reduced.